StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.71+0.04 (+2.36%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

Genprex operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Genprex's operating income for the twelve months ending Jun 30, 2026 was -$15.84M. For fiscal 2025 it was -$15.52M. The highest annual figure on record is -$3.31M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.52M–
FY2024Dec 31, 2024-$21.17M–
FY2023Dec 31, 2023-$31.06M–
FY2022Dec 31, 2022-$23.83M–
FY2021Dec 31, 2021-$20.67M–
FY2020Dec 31, 2020-$17.96M–
FY2019Dec 31, 2019-$10.68M–
FY2018Dec 31, 2018-$12.36M–
FY2017Dec 31, 2017-$3.31M–
FY2016Dec 31, 2016-$4.13M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.48M–
Q1 FY2026Mar 31, 2026-$4.49M–
Q4 FY2025Dec 31, 2025-$3.52M–
Q3 FY2025Sep 30, 2025-$3.35M–
Q2 FY2025Jun 30, 2025-$4.68M–
Q1 FY2025Mar 31, 2025-$3.97M–
Q4 FY2024Dec 31, 2024-$4.34M–
Q3 FY2024Sep 30, 2024-$4.32M–
Q2 FY2024Jun 30, 2024-$6.52M–
Q1 FY2024Mar 31, 2024-$6.00M–
Q4 FY2023Dec 31, 2023-$5.97M–
Q3 FY2023Sep 30, 2023-$7.79M–
Q2 FY2023Jun 30, 2023-$8.04M–
Q1 FY2023Mar 31, 2023-$9.26M–
Q4 FY2022Dec 31, 2022-$6.58M–
Q3 FY2022Sep 30, 2022-$6.17M–
Q2 FY2022Jun 30, 2022-$5.77M–
Q1 FY2022Mar 31, 2022-$5.31M–
Q4 FY2021Dec 31, 2021-$6.75M–
Q3 FY2021Sep 30, 2021-$3.44M–
Q2 FY2021Jun 30, 2021-$3.99M–
Q1 FY2021Mar 31, 2021-$5.31M–
Q4 FY2020Dec 31, 2020-$5.23M–
Q3 FY2020Sep 30, 2020-$2.78M–
Q2 FY2020Jun 30, 2020-$4.38M–
Q1 FY2020Mar 31, 2020-$5.58M–
Q4 FY2019Dec 31, 2019-$2.43M–
Q3 FY2019Sep 30, 2019-$2.38M–
Q2 FY2019Jun 30, 2019-$3.70M–
Q1 FY2019Mar 31, 2019-$2.17M–
Q4 FY2018Dec 31, 2018-$3.44M–
Q3 FY2018Sep 30, 2018-$2.20M–
Q2 FY2018Jun 30, 2018-$6.04M–
Q1 FY2018Mar 31, 2018-$686.63K–
Q4 FY2017Dec 31, 2017-$664.72K–
Q3 FY2017Sep 30, 2017-$715.12K–
Q2 FY2017Jun 30, 2017-$1.18M–
Q1 FY2017Mar 31, 2017-$751.30K–
Q4 FY2016Dec 31, 2016-$999.07K–
Q3 FY2016Sep 30, 2016-$719.86K–

More Genprex figures

See a number that looks wrong?